Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder with limited treatment options. Despite decades of therapeutic development, only two modestly efficacious disease-modifying drugs—riluzole and edaravone—are available to ALS patients. Biomarkers that can facilitate ALS diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Chew, Sheena, Atassi, Nazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405430/
https://www.ncbi.nlm.nih.gov/pubmed/30881332
http://dx.doi.org/10.3389/fneur.2019.00135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405430/
https://www.ncbi.nlm.nih.gov/pubmed/30881332
http://dx.doi.org/10.3389/fneur.2019.00135

Ejemplares similares